59564-59-9,
3,4-dihydroquinoxalin-2(1H)-one,
3,4-Dihydro-1H-quinoxalin-2-one,
3,4-dihydroquinoxalin-2-ol,
3,4-DIHYDRO-2(1H)-QUINOXALINONE,
1,2,3,4-tetrahydroquinoxalin-2-one,
2(1h)-quinoxalinone, 3,4-dihydro-,
1,3,4-trihydroquinoxalin-2-one,
HYTIPJFUWHYQON-UHFFFAOYSA-N,
NSC73534,
AC1L4HTS,
AC1Q6ETU,
ACMC-1AXW3,
AC1Q6M1V,
Oprea1_130717,
Oprea1_146653,
Oprea1_202240,
SCHEMBL37900,
3,4-Dihydroquinoxaline-2-ol,
SCHEMBL8317265,
CTK3J7138,
DTXSID50208236,
WT738,
3,4-Dihydro-2-[1H]quinoxalinone,
ALBB-006577,
3,4-dihydroquinoxaline-2(1H)-one,
ANW-33301,
BBL002392,
BBL007167,
MFCD00204133,
NSC-73534,
SBB017923,
STK500722,
STK506915,
ZINC16916053,
AKOS000271556,
AKOS002337310,
AB04744,
CD-1694,
MCULE-2734535246,
RP21215,
RTR-033300,
KS-000019O3,
AC-29525,
AJ-69599,
AJ-69600,
BAS 04379838,
BS-13392,
CJ-15654,
AB0025730,
AB1006379,
ST2417246,
TR-033300,
AM20040808,
BB 0219703,
CS-0046843,
EU-0033356,
FT-0677245,
ST45028587,
W7241,
EN300-04190,
59564-59-9 3,4-dihydroquinoxalin-2(1H)-one,
A832368,
J-511199,
S14-2254,
F0176-0217,
N-(1,3-benzodioxol-5-ylmethyl)-4-(6-morpholin-4-ylpyrimidin-4-yl)benzamide,
null,
C8H8N2O,
AR-1E9194,
CID185949,
C2677,
H1259,
A-7190,
6626-88-6,